SIA
RMD icon

SGL Investment Advisors’s ResMed RMD Stock Holding History

SGL Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.24M Sell
11,247
-79
-0.7% -$19.7K 0.84% 39
2025
Q4 		$3.02M Buy
11,326
+27
+0.2% +$6.91K 1.21% 30
2025
Q3 		$2.81M Buy
11,299
+229
+2% +$62.6K 1.17% 31
2025
Q2 		$2.84M Sell
11,070
-1,461
-12% -$349K 1.35% 32
2025
Q1 		$3.05M Buy
+12,531
New +$2.93M 1.57% 30

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SGL Investment Advisors's RMD Position: Q1 2026 in Review

SGL Investment Advisors reduced its ResMed (RMD) stake by 0.7% in Q1 2026, selling an estimated $19.7K and leaving 11,247 shares worth $2.24M. The position accounts for 0.84% of the portfolio, ranked #39.

SGL Investment Advisors first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.05M in Q1 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • SGL Investment Advisors held 11,247 shares of ResMed worth $2.24M as of Q1 2026.
  • SGL Investment Advisors sold 79 ResMed shares in Q1 2026, an estimated $19.7K.
  • ResMed made up 0.84% of SGL Investment Advisors's portfolio in Q1 2026, its #39 holding.
  • SGL Investment Advisors first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
  • SGL Investment Advisors's ResMed position peaked at $3.05M in Q1 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SGL Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.